Shanghai HeartCare Medical Technology Corporation Investor Relations

Shanghai HeartCare Medical Technology Corporation Limited engages in the research and development, manufacture, and sale of neuro-interventional medical devices in Mainland China and internationally. It offers ischemic stroke thrombectomy devices, such as Captor Thrombectomy Stent, a thrombectomy stent retriever; aspiration catheter and pump; intracranial stenosis treatment devices, including intracranial drug-eluting balloon stent, embolization protection system, carotid artery stent, and intracranial balloon dilatation catheter and carotid artery balloon dilatation catheter; hemorrhagic stroke treatment devices, including vascular reconstruction device and flow diverter device; and ischemic stroke prevention devices comprising LAA occlude. The company also provides vascular access devices consisting of distal access catheter, microcatheter, balloon guiding catheter, vascular closure device, support catheter, neuro-interventional microcatheter, neuro-interventional micro guidewire, microcatheter for coiling, microcatheter for flow diverter device, and navigation catheter. Its products are used for acute ischemic stroke and neurovascular stenosis treatment, hemorrhagic stroke treatment, ischemic stroke prevention, and interventional access. The company was incorporated in 2016 and is headquartered in Shanghai, the People’s Republic of China.

Read Less